The 11th edition of the International Exhibition on Pharmaceuticals and Healthcare (iPHEX 2025), organised by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) under the aegis of the Ministry of Commerce & Industry, Government of India, was inaugurated on 4 September at Bharat Mandapam, New Delhi.
The inaugural session was graced by Piyush Goyal, Minister for Commerce and Industry, who emphasised India’s critical role in global healthcare and its responsibility to ensure equitable access to affordable, quality medicines. He underlined India’s position as the “Pharmacy of the World” and called for deeper global collaborations to strengthen healthcare systems worldwide.
Bhavin Mehta, Chairman, iPHEX & Vice Chairman, Pharmexcil, said, “As one of the founding members of iPHEX, it is inspiring to see how this initiative has matured into an institution. iPHEX 2025 is focused on empowering MSMEs, driving market intelligence, and sustaining credibility through compliance. From FY14 to FY25, India’s pharmaceutical exports have more than doubled—from $14.9 billion to $30.5 billion— registering an impressive growth of over 104%, a testament to the sector’s resiliesnce, innovation, and expanding global trust. Together, we are shaping the future of Indian pharma as the Partner of First Choice for global healthcare.”
Dr Rajeev Singh Raghuvanshi, Drug Controller General of India, stressed the importance of regulatory convergence and reliance, assuring international stakeholders of India’s commitment to global quality benchmarks.
Namit Joshi, Chairman, Pharmexcil, said, “iPHEX has grown into India’s most credible global touchpoint for pharmaceutical exports. This platform is a direct bridge between policy, regulation, and market opportunity, giving buyers the confidence that Indian exporters deliver not just affordable medicines, but assured quality and global reliability.”
Designed to embody the spirit of “Powering Healthcare, Connecting Markets”, iPHEX 2025 brings together industry leaders, policymakers, and global stakeholders to drive meaningful collaboration, unlock new trade corridors, and elevate India’s role in shaping the future of global healthcare.
